Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: The diabetes control and complications trial/epidemiology of diabetes interventions and complications genetics study

Diabetes

Volumn 57, Issue 1, 2008, Pages 218-228

  Al Kateb, Hussam ^a   Boright, Andrew P ^b   Mirea, Lucia ^c,d   Xie, Xinlei ^c   Sutradhar, Rinku ^c,e   Mowjoodi, Alireza ^a   Bharaj, Bhupinder ^a   Liu, Michelle ^a   Bucksa, Jean M ^f   Arends, Valerie L ^f   Steffes, Michael W ^f   Cleary, Patricia A ^g   Sun, Wanjie ^g   Lachin, John M ^g   Thorner, Paul S ^a,h   Ho, Michael ^a   McKnight, Amy Jayne ⁱ   Maxwell, A Peter ⁱ   Savage, David A ⁱ   Kidd, Kenneth K ^j   Kidd, Judith R ^j   Speed, William C ^j   Orchard, Trevor J ^k   Miller, Rachel G ^k   Sun, Lei ^a,d   Bull, Shelley B ^c,d   Paterson, Andrew D ^a,d   more..

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; COPPER ZINC SUPEROXIDE DISMUTASE; SERINE; ANTIDIABETIC AGENT; NUCLEAR PROTEIN; RNA BINDING PROTEIN; SERINE ARGININE RICH SPLICING PROTEINS; SERINE-ARGININE-RICH SPLICING PROTEINS; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC NEPHROPATHY; DISEASE SEVERITY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; LYMPHOBLAST; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ALBUMINURIA; AMINO ACID SUBSTITUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC RETINOPATHY; DISEASE COURSE; ENZYMOLOGY; GENETICS; GENOTYPE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ALANINE; ALBUMINURIA; AMINO ACID SUBSTITUTION; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; GENOTYPE; HUMANS; HYPOGLYCEMIC AGENTS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA-BINDING PROTEINS; SERINE; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; VARIATION (GENETICS);

EID: 38449106779     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1059     Document Type: Article

References (69)

1. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
2. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992
3. Quinn M, Angelico MC, Warram JH, Krolewski AS: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39:940-945, 1996
4. The Diabetes Control and Complications Trial Research Group: Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes 46:1829-1839, 1997
5. Harjutsalo V, Katoh S, Sarti C, Tajima N, Tuomilehto J: Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes 53:2449-2454, 2004
6. Fioretto P, Steffes MW, Barbosa J, Rich SS, Miller ME, Mauer M: Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes 48:865-869, 1999
7. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS: Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 47:1164-1169, 1998
8. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC, Pima Diabetes Genes Group: Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes 47:821-830, 1998
9. Krolewski AS, Poznik GD, Placha G, Canani L, Dunn J, Walker W, Smiles A, Krolewski B, Fogarty DG, Moczulski D, Araki S, Makita Y, Ng DP, Rogus J, Duggirala R, Rich SS, Warram JH: A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 69:129-136, 2006
10. Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, Rohmeiss P, Basci A, Bartram CR, Van Der Woude FJ, Janssen B: Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62:2176-2183, 2002
11. Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, Fischer C, Rychlik I, Cerna M, Romzova M, de Heer E, Baelde H, Bakker SJ, Zirie M, Rondeau E, Mathieson P, Saleem MA, Meyer J, Koppel H, Sauerhoefer S, Bartram CR, Nawroth P, Hammes HP, Yard BA, Zschocke J, van der Woude FJ: Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 54:2320-2327, 2005
12. Tanaka N, Babazono T, Saito S, Sekine A, Tsunoda T, Haneda M, Tanaka Y, Fujioka T, Kaku K, Kawamori R, Kikkawa R, Iwamoto Y, Nakamura Y, Maeda S: Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms. Diabetes 52:2848-2853, 2003
13. Shimazaki A, Kawamura Y, Kanazawa A, Sekine A, Saito S, Tsunoda T, Koya D, Babazono T, Tanaka Y, Matsuda M, Kawai K, Iiizumi T, Imanishi M, Shinosaki T, Yanagimoto T, Ikeda M, Omachi S, Kashiwagi A, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Nakajima M, Nakamura Y, Maeda S: Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 54:1171-1178, 2005
14. McKnight AJ, Maxwell AP, Sawcer S, Compston A, Setakis E, Patterson CC, Brady HR, Savage DA: A genome-wide DNA microsatellite association screen to identify chromosomal regions harboring candidate genes in diabetic nephropathy. J Am Soc Nephrol 17:831-836, 2006
15. Ewens KG, George RA, Sharma K, Ziyadeh FN, Spielman RS: Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes 54:3305-3318, 2005
16. Hanson RL, Craig DW, Millis MP, Yeatts KA, Kobes S, Pearson JV, Lee AM, Knowler WC, Nelson RG, Wolford JK: Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 56:975-983, 2007
17. Boright AP, Paterson AD, Mirea L, Bull SB, Mowjoodi A, Scherer SW, Zinman B: Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study. Diabetes 54:1238-1244, 2005
18. Ng DP, Tai BC, Koh D, Tan KW, Chia KS: Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 48:1008-1016, 2005
19. Hallman DM, Huber JC Jr, Gonzalez VH, Klein BE, Klein R, Hanis CL: Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care 28:1163-1168, 2005
20. Hallman DM, Boerwinkle E, Gonzalez VH, Klein BE, Klein R, Hanis CL: A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County, Texas. Diabetes 56:1167-1173, 2007
21. Looker HC, Nelson RG, Chew E, Klein R, Klein BE, Knowler WC, Hanson RL: Genome-wide linkage analyses to identify loci for diabetic retinopathy. Diabetes 56:1160-1166, 2007
22. The DCCT Research Group: The Diabetes Control and Complications Trial: design and methodologic considerations for the feasibility phase. Diabetes 35:530-545, 1986
23. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
24. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA: Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74:106-120, 2004
25. Collins FS, Brooks LD, Chakravarti A: A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 8:1229-1231, 1998
26. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265, 2005
27. Gibbs RA, Belmont JW, Hardenbol P, et al.: The International HapMap Project. Nature 426:789-796, 2003
28. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P: A haplotype map of the human genome. Nature 437:1299-1320, 2005
29. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS: BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques Suppl:56-58, 60-61, 2002
30. Al-Kateb H, Mirea L, Xie X, Sun L, Liu M, Chen H, Bull SB, Boright AP, Paterson AD: Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study. Diabetes 56:2161-2168, 2007
31. Cox DR: Regression models and life tables (with discussion). J Royal Stat Soc B 34:187-220, 1972
32. Heinze G, Schemper M: A solution to the problem of monotone likelihood in Cox regression. Biometrics 57:114-119, 2001
33. Heinze G, Ploner M: SAS and SPLUS programs to perform Cox regression without convergence problems. Comput Methods Programs Biomed 67:217-223, 2002
34. Storey JD, Tibshirani R: Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100:9440-9445, 2003
35. Sun L, Craiu RV, Paterson AD, Bull SB: Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies. Genet Epidemiol 30:519-530, 2006
36. Pritchard JK, Stephens M, Donnelly P: Inference of population structure using multilocus genotype data. Genetics 155:945-959, 2000
37. Rosenberg NA, Li LM, Ward R, Pritchard JK: Informativeness of genetic markers for inference of ancestry. Am J Hum Genet 73:1402-1422, 2003
38. Therneau TM, Grambsch PM, Fleming TA: Martingale-based residuals for survival models. Biometrika 77:147-160, 1990
39. Rabinowitz D, Laird N: A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 50:211-223, 2000
40. Horvath S, Xu X, Laird NM: The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 9:301-306, 2001
41. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM: Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 26:61-69, 2004
42. Rakovski CS, Xu X, Lazarus R, Blacker D, Laird NM: A new multimarker test for family-based association studies. Genet Epidemiol 31:9-17, 2007
43. Andersen PK, Borgan O, Gill RD, Keiding N: Statistical Models Based on Counting Processes. New York, Springer-Verlag, 1993
44. Therneau TM, Grambsch PM: Modeling Survival Data: Extending the Cox Model. New York, Springer, 2000
45. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, John Wiley & Sons, 2002
46. Broom WJ, Parton MJ, Vance CA, Russ C, Andersen PM, Hansen V, Leigh PN, Powell JF, Al-Chalabi A, Shaw CE: No association of the SOD1 locus and disease susceptibility or phenotype in sporadic ALS. Neurology 63:2419-2422, 2004
47. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622, 2002
48. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M: Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14:S250-S253, 2003
49. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625, 2005
50. Rosca MG, Mustata TG, Kinter MT, Ozdemir AM, Kern TS, Szweda LI, Brownlee M, Monnier VM, Weiss MF: Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol 289:F420-F430, 2005
51. Sechi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan M, Bartoli E: Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 40:23-29, 1997
52. DeRubertis FR, Craven PA, Melhem MF, Salah EM: Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes 53:762-768, 2004
53. Craven PA, Melhem MF, Phillips SL, DeRubertis FR: Overexpression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 50:2114-2125, 2001
54. Derubertis FR, Craven PA, Melhem MF: Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol. Metabolism 56:1256-1264, 2007
55. Kunishige M, Hill KA, Riemer AM, Farwell KD, Halangoda A, Heinmoller E, Moore SR, Turner DM, Sommer SS: Mutation frequency is reduced in the cerebellum of Big Blue mice overexpressing a human wild type SOD1 gene. Mutat Res 473:139-149, 2001
56. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al.: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62, 1993
57. Gaudette M, Hirano M, Siddique T: Current status of SOD1 mutations in familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:83-89, 2000
58. Selverstone Valentine J, Doucette PA, Zittin Potter S: Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74:563-593, 2005
59. Sherman L, Dafni N, Lieman-Hurwitz J, Groner Y: Nucleotide sequence and expression of human chromosome 21-encoded superoxide dismutase mRNA. Proc Natl Acad Sci U S A 80:5465-5469, 1983
60. Kilk A, Laan M, Torp A: Human CuZn superoxide dismutase enzymatic activity in cells is regulated by the length of the mRNA. FEBS Lett 362:323-327, 1995
61. Hirano M, Hung WY, Cole N, Azim AC, Deng HX, Siddique T: Multiple transcripts of the human Cu, Zn superoxide dismutase gene. Biochem Biophys Res Commun 276:52-56, 2000
62. Hirosawa M, Nagase T, Ishikawa K, Kikuno R, Nomura N, Ohara O: Characterization of cDNA clones selected by the GeneMark analysis from size-fractionated cDNA libraries from human brain. DNA Res 6:329-336, 1999
63. Beavis WD: QTL analyses: power, precision, and accuracy. In Molecular Dissection of Complex Traits. Paterson AH, Ed. New York, CRC Press, 1998, p. 145-162
64. Goring HH, Terwilliger JD, Blangero J: Large upward bias in estimation of locus-specific effects from genomewide scans. Am J Hum Genet 69:1357-1369, 2001
65. Ambroise C, McLachlan GJ: Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci U S A 99:6562-6566, 2002
66. Sun L, Bull SB: Reduction of selection bias in genomewide studies by resampling. Genet Epidemiol 28:352-367, 2005
67. Wu LY, Sun L, Bull SB: Locus-specific heritability estimation via the bootstrap in linkage scans for quantitative trait loci. Hum Hered 62:84-96, 2006
68. Efron B, Tibshirani R: Improvements on cross-validation: the 632+ bootstrap method. J Am Stat Assoc 92:438-548, 1997
69. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research: Principles and Quantitative Methods. Belmont, CA, Lifetime Learning Publications, 1982